NIH's Undiagnosed Diseases Network (UDN) recently released five funding opportunities that continue research in improving the level of diagnosis and care for patients with undiagnosed diseases. The network plans also to study what's required to ensure its sustainability after NIH Common Fund funding ends. Pending the availability of funds and sufficient applications, the program expects to create a coordinating center, 8-10 clinical sites and 3-6 core laboratories to focus on model organisms, DNA sequencing and metabolomics. To help potential applicants, UDN will hold an informational webinar Sept. 14th, from 3:00-4:30 p.m. Eastern.
NHGRI's Division of Intramural Research will present the 13th Jeffrey M. Trent Lecture in Cancer Research Wednesday, Sept. 6, 2017, at the Lipsett Amphitheater, Building 10, NIH. Katherine A. Janeway, M.D., MMSc, the clinical director of the Solid Tumor Program at Dana Farber-Boston/Children's Cancer and Blood Disorders Center, will deliver the lecture Bringing Genomics to the Pediatric Oncology Clinic: Diagnosis, Treatment Selection and Rational Clinical Trial Design.
The American Society of Human Genetics and ten other organizations have just issued a policy statement on human germline genome editing, published August 3rd in the journal American Journal of Human Genetics. Germline editing is adding, removing or replacing parts of DNA in the cells that will get passed down to the next generation. Want to learn more about genome editing? Check out our new resource: Genome Editing.
The National Institutes of Health (NIH) is awarding $18.9 million towards research that aims to accelerates the use of genome sequencing in clinical care. The new awards will generate innovative approaches and best practices to ensure that the effectiveness of genomic medicine can be applied to all individuals and groups, including diverse and underserved populations, and in healthcare settings that extend beyond academic medical centers.
This month's The Genomic Landscape reports on the three-day, 4th ELSI Congress held in June, the tenth genomic medicine meeting, which addressed research in pharmacogenomics and gives a shout out to Three-Minute Talk winner, NHGRI's own Ryan Johnson, Ph.D., a post-doctoral fellow in the laboratory of Julie Segre, PH.D. There's also information on the new executive director of the American Society of Human Genetics.